How to apply for the AACC's Disruptive Technology Award


The February 7 deadline to apply for the American Association for Clinical Chemistry's (AACC) Disruptive Technology Award is drawing close. The award can give a major boost to start-up companies developing new diagnostics technologies, and LabPulse.com talked to AACC President Dr. Stephen Master about how developers can make the most of the competition.

Now in its fifth year, the Disruptive Technology Award is designed to highlight technologies that have the potential to become disruptive advancements in laboratory medicine, Master said. These technologies could fundamentally improve the ability to diagnose certain diseases, or may improve access for existing kinds of testing.

Master explains the competition and how diagnostics companies can apply in the video below.

Deadline nears for AACC Disruptive Technology Award
The deadline is approaching for companies to enter the American Association for Clinical Chemistry's (AACC) Disruptive Technology Award. Applicants have...
Day Zero Diagnostics wins 2021 AACC disruptive tech award
A suite of technologies that diagnose bloodstream infections and sepsis from Day Zero Diagnostics edged out products from two other companies -- one co-founded...
Low-volume test platform from Baebies wins 'disruptive tech' award at AACC
A diagnostic testing platform designed specifically for infants that requires a smaller blood sample beat products from two other companies to win the...
AACC: Inflammatix sepsis test wins Disruptive Technology contest
ANAHEIM, CA - A blood test for sepsis developed by California startup Inflammatix beat out products from two other companies to win the Disruptive Technology...
GNA Biosolutions secures $13.5M in new funding round
Molecular diagnostics company GNA Biosolutions has raised $13.5 million in a series C financing round backed by a U.S. and European consortium.

Copyright © 2022 LabPulse.com

Last Updated bc 1/27/2022 7:35:17 AM